Endocrinology - Obesity and lipids

Obesity is a serious health problem that is increasing in society. Overweight and obesity are important risk factors for heart disease. Many risk factors for heart disease have been suggested in overweight and obese people, including dyslipidemia and irritability. Adiponectin, a hormone released by adipose tissue, has both weight loss and weight loss properties. Numerous studies have explained the relationship between adiponectin and obesity in different populations. LDL cholesterol plays an important role in this "diabetic dyslipidemia" and is considered to be severely atherogenic, a greater cause than a clear indication of increased risk. A variation known as VLDL, low-density lipoprotein, appears to be particularly dangerous—but it appears that increasing HDL, high-density lipoprotein cholesterol, can control its harmful activity or no decrease associated with LDL counts.

  • Elevated Cholesterol
  • Elevated Triglycerides
  • Elevated Triglycerides
  • Obesity/Metabolic Syndrome

Related Conference of Endocrinology - Obesity and lipids

July 20-21, 2026

6th World Congress on Endocrine and Diabetes

Paris, France
September 29-30, 2026

22nd World Congress on Endocrinology & Diabetes

Paris, France
October 20-21, 2026

32nd World Diabetes & Heart Congress

Amsterdam, Netherlands
October 22-23, 2026

4th World congress and Expo on Diabetes

Toronto, Canada
February 25-26, 2027

20th International Summit on Diabetes

London, UK
March 23-24, 2027

7th Annual Summit on Diabetes and Endocrinology

Paris, France
March 29-30, 2027

8th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands

Endocrinology - Obesity and lipids Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in